Mirna-mediated silencing of β-Secretase 1 (base 1): perspectives to a therapeutic approach to Alzheimer disease
DOI:
https://doi.org/10.17533/udea.iatreia.4192Abstract
Alzheimer's disease (AD) is characterized by two cerebral lesions associated to its phatology: amyloid plaques ( β-amyloid aggregates) and neurofibrillar tangles (Tau protein aggregates).
|Abstract = 97 veces
Downloads
Download data is not yet available.
Published
2005-03-14
How to Cite
1.
Aristizábal D, Hernández I, Lópera J, Boudreau R, Gallego Gómez JC, Cardona Gómez GP. Mirna-mediated silencing of β-Secretase 1 (base 1): perspectives to a therapeutic approach to Alzheimer disease. Iatreia [Internet]. 2005 Mar. 14 [cited 2025 Mar. 5];18(4-S):pág. S-26. Available from: https://revistas.udea.edu.co/index.php/iatreia/article/view/4192
Issue
Section
Abstracts
License
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
